Select Topic:
Browse by Series:

Later Lines of Therapy for Metastatic Colorectal Cancer

Insights From: Tanios Bekaii-Saab, MD, Mayo Clinic; Johanna C. Bendell, MD, Sarah Cannon Research Institute
Published: Tuesday, Nov 13, 2018



Transcript:

Tanios Bekaii-Saab, MD: Almost 90% or more of patients who progressed through first-line therapy will make it to the second line. Second-line options will depend on what you
Slider Left
Slider Right


Transcript:

Tanios Bekaii-Saab, MD: Almost 90% or more of patients who progressed through first-line therapy will make it to the second line. Second-line options will depend on what you
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x